ftInvstr

LASA · Healthcare ₹4.22 -4.95% Mkt Cap ₹21 Cr

LASA

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹4.22

-4.95% today · 30d -42.43%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for LASA. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹1 Cr

-93.87% YoY

NET PROFIT

₹-4 Cr

OPM

-97.51%

-95.68pp YoY

EPS

₹0.71

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-108.7% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

LASA——

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 5

Valuation — —

Growth DECLINING 24

Profitability LOW 5

Technicals BEARISH 18

Risk LOW 90

Key Stats

P/B

0.43

52W HIGH

₹14.08

OFF HIGH

-70.03%

DIV YIELD

0.0%

MKT CAP

₹21 Cr

◉ Active Signals

MACDBearish-0.2072

RSI(14)Bullish12.35

Near 52W LowBearish0.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold LASA and at what entry.